United States · FDA National Drug Code directory

Relivyx Plus

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
72835-555_7485ec1d-074d-4e47-a555-8994173ceb78
Product NDC
72835-555
Form
KIT
Composition / generic term
Lidocaine
Labeler
V2 Pharma LLC
Marketing category
UNAPPROVED DRUG OTHER
Marketing start / end (source format)
20260331
Source listing expiry
20271231

Source-listed ingredients

Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 KIT in 1 CARTON (72835-555-02) * 30 POUCH in 1 PACKAGE (82347-0505-5) / 14 g in 1 POUCH (82347-0505-4) * 89 g in 1 BOTTLE, PLASTIC (72667-073-01) · 72835-555-02

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →